<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>NORGESIC- orphenadrine citrate, aspirin and caffeineÂ tablet, multilayerÂ </strong><br><strong>NORGESIC FORTE- orphenadrine citrate, aspirin and caffeineÂ tablet, multilayerÂ </strong><br>3M Pharmaceuticals<br></p></div>
<h1><span class="Bold">Norgesicâ„¢ AND Norgesicâ„¢ Forte</span></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s1"></a><a name="section-1"></a><p></p>
<p class="First">TABLETS</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s2"></a><a name="section-2"></a><p></p>
<h1>ACTIONS</h1>
<p class="First">Orphenadrine citrate is a centrally acting (brain stem) compound which in animals selectively blocks facilitatory functions of the reticular formation.  Orphenadrine does not produce myoneural block, nor does it affect crossed extensor reflexes.  Orphenadrine prevents nicotine-induced <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span> but not those produced by strychnine.</p>
<p>Chronic administration of Norgesic to dogs and rats has revealed no drug-related toxicity.  No blood or urine changes were observed, nor were there any macroscopic or microscopic pathological changes detected.  Extensive experience with combinations containing aspirin and caffeine has established them as safe agents.  The addition of orphenadrine citrate does not alter the toxicity of aspirin and caffeine.</p>
<p>The mode of therapeutic action of orphenadrine has not been clearly identified, but may be related to its analgesic properties.  Orphenadrine citrate also possesses anticholinergic actions.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="s3"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS</h1>
<dl>
<dt>â€¢</dt>
<dd>Symptomatic relief of mild to moderate <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> of acute <span class="product-label-link" type="condition" conceptid="4244662" conceptname="Disorder of musculoskeletal system">musculoskeletal disorders</span>.</dd>
<dt>â€¢</dt>
<dd>The orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">discomfort</span> associated with acute painful musculoskeletal conditions.</dd>
</dl>
<p class="First">The mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties.  Norgesic and Norgesic Forte do not directly relax <span class="product-label-link" type="condition" conceptid="4136244" conceptname="Feeling tense">tense</span> skeletal muscles in man.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="s4"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Because of the mild anticholinergic effect of orphenadrine, Norgesic or Norgesic Forte should not be used in patients with <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>, pyloric or duodenal obstruction, achalasia, <span class="product-label-link" type="condition" conceptid="198803" conceptname="Benign prostatic hyperplasia">prostatic hypertrophy</span> or obstructions at the bladder neck.  Norgesic or Norgesic Forte is also contraindicated in patients with <span class="product-label-link" type="condition" conceptid="76685" conceptname="Myasthenia gravis">myasthenia gravis</span> and in patients known to be sensitive to aspirin or caffeine.</p>
<p>The drug is contraindicated in patients who have demonstrated a previous <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to the drug.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="s5"></a><a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Reye's Syndrome may develop in individuals who have chicken pox, <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span>, or <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">flu symptoms</span>.  Some studies suggest a possible association between the development of Reye's Syndrome and the use of medicines containing salicylate or aspirin.  Norgesic and Norgesic Forte contain aspirin and therefore are not recommended for use in patients with chicken pox, <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">influenza</span>, or <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">flu symptoms</span>.</p>
<p>Norgesic and Norgesic Forte may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or driving a motor vehicle; ambulatory patients should therefore be cautioned accordingly.</p>
<p>Aspirin should be used with extreme caution in the presence of <span class="product-label-link" type="condition" conceptid="4027663" conceptname="Peptic ulcer">peptic ulcers</span> and coagulation abnormalities.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="s6"></a><a name="section-6"></a><p></p>
<h1>USAGE IN PREGNANCY</h1>
<p class="First">Since safety of the use of this preparation in pregnancy, during lactation, or in the childbearing age has not been established, use of the drug in such patients requires that the potential benefits of the drug be weighed against its possible hazard to the mother and child.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="s7"></a><a name="section-7"></a><p></p>
<h1>PEDIATRIC USE</h1>
<p class="First">Safety and effectiveness in pediatric patients have not been established.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="s8"></a><a name="section-8"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">Confusion</span>, <span class="product-label-link" type="condition" conceptid="441542" conceptname="Anxiety">anxiety</span> and <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremors</span> have been reported in a few patients receiving propoxyphene and orphenadrine concomitantly.  As these symptoms may be simply due to an additive effect, reduction of dosage and/or discontinuation of one or both agents is recommended in such cases.</p>
<p>Safety of continuous long term therapy with Norgesic and Norgesic Forte has not been established; therefore, if Norgesic or Norgesic Forte is prescribed for prolonged use, periodic monitoring of blood, urine and liver function values is recommended.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="s9"></a><a name="section-9"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Side effects of Norgesic or Norgesic Forte are those seen with aspirin and caffeine or those usually associated with mild anticholinergic agents.  These may include <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitation</span>, <span class="product-label-link" type="condition" conceptid="201688" conceptname="Delay when starting to pass urine">urinary hesitancy</span> or retention, <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">dry mouth</span>, <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>, dilatation of the pupil, increased intraocular <span class="product-label-link" type="condition" conceptid="4200706" conceptname="Tension">tension</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, and rarely, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span> and other dermatoses.  Infrequently, an elderly patient may experience some degree of <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span>.  Mild central excitation and occasional <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span> may be observed.  These mild side effects can usually be eliminated by reduction in dosage.  One case of <span class="product-label-link" type="condition" conceptid="137829" conceptname="Aplastic anemia">aplastic anemia</span> associated with the use of Norgesic has been reported.  No causal relationship has been established.  Rare G.I. <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">hemorrhage</span> due to aspirin content may be associated with the administration of Norgesic or Norgesic Forte.  Some patients may experience transient episodes of light-headedness, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span> or <span class="product-label-link" type="condition" conceptid="135360" conceptname="Syncope">syncope</span>.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="s10"></a><a name="section-10"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Norgesic:  Adults 1 to 2 tablets 3 to 4 times daily.</p>
<p>Norgesic Forte:  Adults Â½ to 1 tablet 3 to 4 times daily.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="s11"></a><a name="section-11"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Norgesic tablets can be identified by their two layers colored white and yellow.  Each round tablet is embossed â€œNORGESICâ€? on one side and â€œ3Mâ€? on the other and contains orphenadrine citrate (2-dimethylaminoethyl 2-methylbenzhydryl ether citrate) 25 mg, aspirin 385 mg, and caffeineÂ 30Â mg.</p>
<p>Norgesic Forte tablets are exactly twice the strength of Norgesic.  They are identified by their scored capsule shape and by their two layers colored white and yellow.  Each capsule shaped tablet is embossed â€œNORGESIC FORTEâ€? on one side and â€œ3Mâ€? on the other and contains orphenadrine citrate 50 mg, aspirin 770 mg, and caffeine 60 mg.</p>
<p>Norgesic and Norgesic Forte also contain: lactose, polyethylene glycol, povidone, starch, sucrose, zinc stearate, and D&amp;C yellow #10.</p>
<p>Norgesic: Bottles of 100 tablets (<span class="Bold">NDC 0089-0231-10</span>) and 500 tablets (<span class="Bold">NDCÂ 0089-0231-50</span>).</p>
<p>Norgesic Forte: Bottles of 100 tablets (<span class="Bold">NDC 0089-0233-10</span>) and 500 tablets (<span class="Bold">NDCÂ 0089-0233-50</span>).</p>
<p>Store below 30Â°C (86Â°F).</p>
<p><span class="Bold">Rx only</span></p>
<p>600600 MAY 1998</p>
<p><span class="Bold">3M Pharmaceuticals</span></p>
<p>Northridge, CA 91324</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_7defbce9-6385-4db8-b284-780ba7502292"></a><a name="section-12"></a><p></p>
<h1>Package/Label Display Panel</h1>
<p class="First">IMAGE NOT AVAILABLE</p>
<div class="Figure">
<a name="id2107776698"></a><img alt="IMAGE NOT AVAILABEL" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a7fa86b5-2154-4b17-9265-8a5411c88d5d&amp;name=IMAGE%20NOT%20AVAILABEL.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_ec1a80d1-3465-416f-a9b4-dd0c843c58a9"></a><a name="section-13"></a><p></p>
<h1>Package/Label Display Panel</h1>
<p class="First">IMAGE NOT AVAILABLE</p>
<div class="Figure">
<a name="id79500150"></a><img alt="2ND IMAGE NOT AVAILABLE" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a7fa86b5-2154-4b17-9265-8a5411c88d5d&amp;name=2ND%20IMAGE%20NOT%20AVAILABLE.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>NORGESICÂ 		
					</strong><br><span class="contentTableReg">orphenadrine citrate, aspirin and caffeine tablet, multilayer</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0089-0231</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>orphenadrine citrate</strong> (orphenadrine) </td>
<td class="formItem">orphenadrine citrate</td>
<td class="formItem">25Â mg</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>aspirin</strong> (aspirin) </td>
<td class="formItem">aspirin</td>
<td class="formItem">385Â mg</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>caffeine</strong> (caffeine) </td>
<td class="formItem">caffeine</td>
<td class="formItem">30Â mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>LACTOSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POVIDONES</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SUCROSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>ZINC STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>D&amp;C YELLOW NO. 10</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE (WHITE) </td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND (ROUND) </td>
<td class="formLabel">Size</td>
<td class="formItem">11mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">NORGESIC;3M</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0089-0231-10</td>
<td class="formItem">100  in 1 BOTTLE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:0089-0231-50</td>
<td class="formItem">500  in 1 BOTTLE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA013416</td>
<td class="formItem">03/04/1964</td>
<td class="formItem">12/31/2015</td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>NORGESIC FORTEÂ 		
					</strong><br><span class="contentTableReg">orphenadrine citrate, aspirin and caffeine tablet, multilayer</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0089-0233</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>orphenadrine citrate</strong> (orphenadrine) </td>
<td class="formItem">orphenadrine citrate</td>
<td class="formItem">50Â mg</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>aspirin</strong> (aspirin) </td>
<td class="formItem">aspirin</td>
<td class="formItem">770Â mg</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>caffeine</strong> (caffeine) </td>
<td class="formItem">caffeine</td>
<td class="formItem">60Â mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>LACTOSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POVIDONES</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SUCROSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>ZINC STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>D&amp;C YELLOW NO. 10</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE (WHITE) </td>
<td class="formLabel">Score</td>
<td class="formItem">2 pieces</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">OVAL (CAPSULE) </td>
<td class="formLabel">Size</td>
<td class="formItem">19mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">NORGESIC;FORTE;3M</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0089-0233-10</td>
<td class="formItem">100  in 1 BOTTLE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:0089-0233-50</td>
<td class="formItem">500  in 1 BOTTLE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA013416</td>
<td class="formItem">03/04/1964</td>
<td class="formItem">12/31/2015</td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>3M Pharmaceuticals
							(006173082)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 5/2006<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>58d13d43-72c8-4af3-b65b-81130aeb4023</div>
<div>Set id: a7fa86b5-2154-4b17-9265-8a5411c88d5d</div>
<div>Version: 4</div>
<div>Effective Time: 20060511</div>
</div>
</div>Â <div class="DistributorName">3M Pharmaceuticals</div></p>
</body></html>
